Twist Bioscience Corp: CFO Adam Laponis sold 2,462 shares

What happened

• Adam Laponis, CFO, sold 2,462 shares at $156.30 per share on Oct 9, 2026, for $384,823. The transaction is reported as an open market or private sale (code S).

Key details

• Transaction date and price: Oct 9, 2026 — 2,462 shares at $156.30.
• Shares owned after the transaction: the filing does not report shares owned following the sale.
• Footnote F1: sale required to cover tax withholding in connection with the vesting of restricted stock units; sales were mandated by the issuer's election to use a "sell to cover" transaction and do not represent discretionary trades by the reporting person.
• Form 4 filed Oct 13, 2026; the filing does not indicate a late filing.

Why it may matter

• The filing indicates this was a sell-to-cover tied to RSU vesting (tax withholding), not a voluntary open-market decision by the reporting person.
• A filing does not show why the insider traded or why the company acted.